Work

Assessing the overall benefit of a medication: cumulative benefit of secukinumab over time in patients with moderate-to-severe plaque psoriasis

Year: 2016

Type: article

Source: Journal of Dermatological Treatment

DOI: 10.1080/09546634.2016.1214667

Authors: April W. Armstrong, Steven R. Feldman, Neil J. Korman, Xiangyi Meng, Adriana Guana, Judit Nyirady, Vivian Herrera, Yang Zhao

Institutions: University of Southern California, Atrium Health Wake Forest Baptist, University Hospitals of Cleveland, University Hospitals Cleveland Medical Center

Language: English

Topic: Psoriasis: Treatment and Pathogenesis

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Novartis Pharmaceuticals Corporation

OpenAlex ID: W2511777977

FWCI: 1.013

Cites: 20

Cited by: 16

Related to: 10